Deep, targeted next-generation sequencing has exposed that subclonal mutations (i.e., These present in only a fraction of tumor cells) can be detected for all driver genes and they are associated with rapid sickness development and inadequate end result.11–13 This is particularly relevant for TP53aberrations and in shape plenty of to tolerate FCR